BLACKROCK BIOTECHNOLOGY ETF | IBB

Medium RiskEquityMorning Star3 / 5
BLACKROCK BIOTECHNOLOGY ETF
Issued by:iShares by Blackrock
Index : NASDAQ
Unit Price (NAV) :
$
Minimum investment: 1 unit
Share
Compare
Share
Compare
BLACKROCK BIOTECHNOLOGY ETF | IBB

BLACKROCK BIOTECHNOLOGY ETF | IBB

About IBB ETF

Biotechnology is the 'next big thing' in the technology sector. The Blackrock Biotechnology ETF (IBB) provides targeted exposure to equities in the biotechnology and pharmaceuticals sectors trading on the NASDAQ.

IBB ChartsLifetime17.61%
IBB Performance1Y3Y5Y10Y
This ETF26.92%8.34%1.26%17.68%

Projected Returns

Investment ofper month
gives returns of :
at 17.68% / annum
$in 10 years
amount
for a time period of
time1Y3Y5Y10Y
Returns % (CAGR)based on historic returns of 17.68% per annum
$
$
$+ 17.68%

Asset Class

Asset type breakdown
Stock US92%
Stock non-US7.93%
Cash0.08%

IBB Holdings - Top 10

NameiWeightage (%)
Amgen Inc8.07%
Vertex Pharmaceuticals Incorporated7.86%
Gilead Sciences, Inc7.77%
Regeneron Pharmaceuticals, Inc6.56%
Illumina, Inc5.68%
Biogen Inc3.42%
Seattle Genetics, Inc3.14%
Moderna, Inc2.66%
Alexion Pharmaceuticals, Inc2.65%
Incyte Corporation2.41%

IBB Sectors/Industry Breakdown

Sectori% of market value
Healthcare99.90%
Basic Materials0.10%

IBB Countries

Country% of market value
North America92.23%
Europe Developed3.55%
Asia Emerging2.48%
United Kingdom1.44%
Asia Developed0.17%
Africa/Middle East0.13%

IBB Summary Data

Fund Size(AUM) $i
Avg. mkt. cap (MM) $i
Morningstar Ratings 3i
Symbol IBB
Exchange XNAS
ISIN US4642875565
Cat. Benchmark MSCI ACWI NR USD
Asset class Equity
Category Health
Country US

IBB Portfolio Data & Volatility Analysis

Expense ratio 0.47i
Beta 1.01i
P/E ratio 17.67549i
Standard Deviation 22.51i

Fund Strategy

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

IBB Fact Sheets & Reports

downloadProspectus
downloadFactsheet

About iShares by Blackrock

With more than twenty years of ETF experience, a global line-up of 800+ exchange-traded funds (ETFs) and $1.9 trillion in assets under management, iShares continually strives to unlock new opportunities for our investors. By channeling strategic thinking and expertise into a robust offering of investment funds, iShares aims to make wealth-building easier, more efficient, and more rewarding for all investors.

BLACKROCK BIOTECHNOLOGY ETF | IBB